Table 3

Results of Fine-Gray (competing risks) regression comparing the risk of serious self-harm between study treatment groups

Unadjusted, SHR (95% CI)Age-sex adjusted, SHR (95% CI)Propensity score weighted, SHR (95% CI)
Mirtazapine vs SSRI1.35 (0.99 to 1.84)1.51 (1.11 to 2.06)1.18 (0.84 to 1.65)
Mirtazapine vs amitriptyline5.06 (2.42 to 10.59)4.33 (2.05 to 9.11)3.04 (1.36 to 6.79)
Mirtazapine vs venlafaxine0.84 (0.53 to 1.32)0.94 (0.59 to 1.48)0.85 (0.51 to 1.41)
  • SHR, subdistribution hazard ratio; SSRI, selective serotonin reuptake inhibitor.